NASDAQ: RDUS       Radius Health
Last Price Today's Change   Day's Range   Trading Volume
21.27   -0.42 (1.94%)  20.50 - 22.13  334,092


Avg Volume (4 weeks):511,933
4 Weeks Range:17.70 - 23.304
4 Weeks Price Volatility (%):
52 Weeks Range:10.151 - 23.304
52 Weeks Price Volatility (%):
Average Price Target: 56.00
Price Target Upside/Downside: +34.73


No recent Headlines for this stock.

Business Background

Radius Health Inc is a specialty and generic drug manufacturing company. The company has one business segment, Pharmaceuticals, that develops and sells therapeutics in the areas of oncology, osteoporosis, and endocrine diseases. One of Radius' product candidates is Abaloparatide-SC, which is an injectable subcutaneous formulation of abaloparatide, utilized to treat postmenopausal osteoporosis. Another product candidate in clinical trials is RAD1901, a selective estrogen receptor down-regulator/degrader, utilized to treat metastatic breast cancer. The company generates the majority of its revenue in the United States.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

2878  3560  211  3248 

Top 10 Active Counters
 AMC 4.42+0.91 
 BB 18.03+3.99 
 EXPR 4.15+2.36 
 NOK 4.85+0.65 
 SNDL 0.60-0.045 
 PLTR 36.23+3.65 
 CTRM 0.381-0.024 
 GME 76.79+11.78 
 LK 1.38+1.38 
 AAPL 142.92+3.85